Healthcare Industry News: Interbody fusion device
News Release - March 22, 2013
Spine Surgeons Embrace Uniquely Effective Valeo Interbody Fusion Devices As Amedica Announces 10,000 ImplantationsProprietary Silicon Nitride Technology Provides Surgeons with Superior Capabilities to Increase Quality Care for Patients Suffering from Back Pain
SALT LAKE CITY, March 22, 2013 -- (Healthcare Sales & Marketing Network) -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, today announced the 10,000th worldwide implantation of its Valeo Interbody fusion devices. The Valeo Interbody fusion device System, made of Amedica's proprietary Silicon Nitride ceramic technology, is used during surgical procedures to treat spinal disorders such as spondylolisthesis, scoliosis, severe disc degeneration, or spinal fractures.
Due to its proven record of superior new bone growth and antibacterial properties, surgeons at leading hospitals worldwide are increasingly relying on Valeo Silicon Nitride Interbody fusion devices to increase the probability of fusion.
"In my four years of experience with Silicon Nitride Interbody fusion devices, I've seen the material exceed the capabilities of poly-ether-ether-ketone (PEEK) and titanium (Ti), resulting in better fusion, which translates to better results for my patients," said Dr. Grant Skidmore of Neurosurgical Specialists, Inc., in Norfolk, Va. "As a spinal surgeon, my paramount concern is getting my patients back to their daily activities as soon as possible. Patients who I've treated with Valeo implants have had a quicker recovery time compared to traditional implants."
The Valeo Interbody fusion device System includes cervical and lumbar implants designed to participate in the fusion process, optimizing patient outcomes. The implants are semi-radiolucent allowing surgeons to ascertain exact placement intra-operatively and improve post-operative monitoring. Valeo Interbody fusion devices do not cause MRI or CT artifacts which can make imaging interpretation difficult.
"The success of the Valeo Interbody fusion device System is a testament to the proven safety and effectiveness of our Silicon Nitride technology," said Eric K. Olson, President and Chief Executive Officer, Amedica. "As we continue to work toward a new standard of care for Interbody fusion devices, we are pleased to see a continued increase in physician adoption. We are greatly encouraged for the future of this technology."
Additional information about the Company's complete line of products may be found at www.amedica.com.
About Amedica Corporation:
Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications made possible with the use of its silicon nitride ceramic technologies. Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.
Source: Amedica Corp
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.